Capital Construction Snapshot: Pharma-Bio Industry to Invest More Than $3 Billion in Fourth-Quarter 2012 Project Starts, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 10/19/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With but a scant three months left of 2012, the is on track to an impressive finish in North America. The sector is set to launch a whopping $3 billion of capital construction and maintenance projects during the fourth quarter. That money is targeted for investment in 257 projects, delivering an average total investment value of $12 million per project.
Other companies featured: (NYSE:JNJ), (NASDAQ:REGN)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.10.2012 - 04:15 Uhr
Sprache: Deutsch
News-ID 1161821
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 202 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Capital Construction Snapshot: Pharma-Bio Industry to Invest More Than $3 Billion in Fourth-Quarter 2012 Project Starts, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
